Multiple Sclerosis Journal · 2015 · 375 citations · 28 references
MedicineNeurologyNeuroscienceNeuro-ophthalmologyNeuroimmunologyNeuropathologyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisOptic NeuritisOptic NeuropathiesMog Antibody DiseaseMog Antibody-associated DiseaseMog Antibody-associated Optic NeuritisMultiple Sclerosis-associated Optic NeuritisMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseMyelin-associated GlycoproteinOptic Nerve DemyelinationOptic Tract
Recognizing the underlying cause of optic neuritis is critical for guiding treatment and preserving vision. The study aimed to delineate the radiological characteristics of first‑episode demyelinating optic neuritis. Blinded radiological review was conducted on 50 patients with first‑episode MOG‑associated, AQP4‑associated, MS‑associated, and unclassified optic neuritis. Compared with MS‑associated optic neuritis, MOG‑ and AQP4‑associated cases were more often bilateral and longitudinally extensive, with MOG‑ON showing anterior optic‑pathway involvement and optic‑nerve‑head swelling, AQP4‑ON exhibiting posterior pathway, chiasmal, and optic‑tract involvement, and a combination of absent brain MRI abnormalities and higher lesion‑extent scores effectively distinguishing autoantibody‑associated ON from MS, while AQP4‑ON was linked to more severe visual loss.
Background: Recognizing the cause of optic neuritis (ON) affects treatment decisions and visual outcomes. Objective: We aimed to define radiological features of first-episode demyelinating ON. Methods: We performed blinded radiological assessment of 50 patients presenting with first-episode myelin oligodendrocyte glycoprotein (MOG) antibody-associated ON (MOG-ON; n=19), aquaporin-4 (AQP4) antibody-associated ON (AQP4-ON; n=11), multiple sclerosis (MS)-associated ON (MS-ON; n=13), and unclassified ON ( n=7). Results: Bilateral involvement was more common in MOG-ON and AQP4-ON than MS-ON (84% vs. 82% vs. 23%), optic nerve head swelling was more common in MOG-ON (53% vs. 9% vs. 0%), chiasmal involvement was more common in AQP4-ON (5% vs. 64% vs. 15%), and bilateral optic tract involvement was more common in AQP4-ON (0% vs. 45% vs. 0%). Retrobulbar involvement was more common in MOG-ON, whereas intracranial involvement was more common in AQP4-ON. MOG-ON and AQP4-ON had longer lesion lengths than MS-ON. The combination of two predictors, the absence of magnetic resonance imaging brain abnormalities and a higher lesion extent score, showed a good ability to discriminate between an autoantibody-associated ON (MOG or AQP4) and MS. AQP4-ON more frequently had severe and sustained visual impairment. Conclusion: MOG-ON and AQP4-ON are more commonly bilateral and longitudinally extensive. MOG-ON tends to involve the anterior optic pathway, whereas AQP4-ON the posterior optic pathway.
28
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
Alastair Compston, Alasdair Coles · The Lancet · 2008 · 4.3K citations
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations
Life Sciences, Immunology, Neurology +14